Inovalon Reports Second Quarter 2019 Results

    NEXT STORY
    Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect and Monitor Minimal Residual Disease (MRD) in Patients with Certain Blood Cancers
    PREV STORY
    MacroGenics Provides Update on Corporate Progress and Second Quarter 2019 Financial Results
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Melinta Therapeutics Provides Corporate Updates

    ~ Highlights Continued Positive Sales Momentum and Estimated Year-End Cash Position ~ ~ Confirms ...

    author_avatar
    NASDAQ Market News

    Paratek Pharmaceuticals Launches NUZYRA™ (Omadacycline) in the United States

    -- Three Antimicrobial Susceptibility Tests Cleared by FDA for Use with NUZYRA -- -- ...

    author_avatar
    NASDAQ Market News

    Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

    BERKELEY, Calif., May 10, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

    author_avatar
    NASDAQ Market News